An analytical chemist prepares a sample of a hydrophobic peptide for reverse-phase HPLC and passes it through a syringe filter, as the method requires. The filter feels unusually resistant, and the resulting chromatogram shows a clean main peak with a high area-percent purity. A colleague repeating the analysis a week later, from a solution that stood longer before analysis, gets a lower main-peak area and a broad hump late in the run. Neither result is simply wrong. Both are shaped by aggregation, the tendency of some peptides to associate with each other in solution.
Aggregation matters to anyone interpreting analytical data, because material that has left solution is invisible to a method that only measures what reaches the detector. This article explains the behavior as physical chemistry; it is not handling guidance for any product.
What the purity number can miss
An area-percent purity figure describes the sample that was introduced onto the column. Anything removed by filtration beforehand was never counted. If a portion of the peptide had already formed insoluble aggregates, the filter took them out, and the chromatogram reports on what was left. The result can look better than the material in the container would justify.
Soluble aggregates that do reach the column behave differently. On a reverse-phase system they tend to appear as broad, late-eluting features, or they bind so strongly that they never elute during the run. Neither case is a clean measurement of how much aggregated material was present. How to read those features is covered in how to read an HPLC chromatogram, and why purity can differ between laboratories is discussed in why suppliers report different peptide purity.
Measuring oligomers as oligomers needs a technique that separates by size rather than hydrophobicity. Size-exclusion chromatography sorts molecules by hydrodynamic size and can resolve monomer from dimer and larger species. It is not part of a standard identity and purity package.
Peptides containing cysteine add one more possibility. Two molecules can form an intermolecular disulfide bond, producing a covalent dimer. Unlike a loosely associated aggregate, that dimer has its own mass and persists through conditions that would break up non-covalent assemblies, so mass spectrometry can detect it directly.
Why association starts, and why it can seem sudden
Every dissolved peptide molecule interacts with two things: the solvent around it and other peptide molecules. When interactions between peptide molecules become more favorable than interactions with solvent, molecules begin to associate. Small soluble oligomers form first, then larger assemblies, and eventually visible particles that settle or coat container surfaces.
The timing often surprises people. Aggregation commonly follows a nucleation mechanism: a small, stable seed must form before growth accelerates. Until a seed appears, a solution can look unchanged for hours. Once one forms, growth can proceed quickly. That lag phase explains the opening example, where a solution analyzed promptly and one analyzed later gave different pictures.
Reading aggregation risk from the sequence
Much of a peptide’s tendency to aggregate is written into its sequence and can be estimated before any experiment:
| Sequence feature | Effect on aggregation tendency | Reason |
|---|---|---|
| Runs of valine, isoleucine, leucine or phenylalanine | Increases | Non-polar side chains associate with each other rather than with water |
| High beta-sheet propensity | Increases | Extended strands hydrogen-bond into tightly packed, stable sheets |
| Substantial net charge at the working pH | Decreases | Like charges repel and keep molecules apart |
| pH near the isoelectric point | Increases | Net charge approaches zero and repulsion is lost |
| Longer chain length | Generally increases | More surface available for intermolecular contact |
The isoelectric point deserves emphasis. Solubility is typically lowest near the pH at which a peptide carries no net charge, so the same peptide can behave very differently in an acidic mobile phase than in a near-neutral buffer.
Conditions that shift the balance
Beyond the sequence, several conditions influence how fast association proceeds. They are the variables an analyst needs to know when comparing results from different laboratories or different days.
- Concentration. The dominant factor. Association requires molecules to meet, so its rate rises steeply as concentration increases. A peptide that stays in solution at a low concentration may aggregate at a higher one.
- Agitation. Vigorous shaking or vortexing creates air-liquid interfaces. Peptides adsorb there and can partially unfold, which seeds further association. Its effect is often underestimated.
- Temperature. Ambiguous. Warming can improve solubility and also accelerate association, so its net effect depends on the sequence.
- Freezing. As ice forms, solutes are concentrated in the remaining liquid, creating conditions that favor association. Freeze-thaw cycles are a known driver of aggregation.
Clear is not the same as monomeric
Visible signs of aggregation, such as haze, particles or a film on the container wall, appear only late in the process. The early stages involve small soluble oligomers that scatter too little light to see. A solution that looks perfectly clear can therefore still contain a meaningful fraction of associated species. Visual inspection catches the advanced cases; only a size-based method characterizes the early ones.
Implications for interpreting analytical data
For anyone comparing purity results, aggregation suggests a handful of questions worth asking. Was the sample filtered, and was the filter examined? How long did the solution stand before analysis, and at what concentration was it prepared for the method? Does the chromatogram show broad late features, or does a subsequent blank run show material eluting that should have come off earlier? Is the peptide one whose sequence predicts aggregation, and was any size-based method used?
None of these questions implies that a published result is wrong. They define what the result measured. A purity figure from a hydrophobic, low-charge sequence is a statement about the soluble fraction under the method’s conditions. The underlying material is supplied as a dry solid, and its lyophilized form is one reason the solid state is the stable reference point for testing.
Independent reverse-phase HPLC results are published per product across the Battle Born catalog. Like any reverse-phase purity figure, it reports what the method separated and detected.
Questions
Can an aggregated peptide still show high HPLC purity?
Yes. If insoluble aggregates are removed by filtration before analysis, the chromatogram measures only what remained in solution.
Which technique measures aggregates directly?
Size-exclusion chromatography separates species by hydrodynamic size and can resolve monomers from oligomers. Covalent disulfide dimers can also be detected by mass spectrometry.
Why does aggregation seem to begin suddenly?
Many peptides aggregate by nucleation. A lag phase precedes the formation of a stable seed, after which growth accelerates.
Which peptides are most prone to aggregate?
Those with hydrophobic stretches, strong beta-sheet propensity and little net charge at the relevant pH, particularly near their isoelectric point.
Research use only. All products supplied by Battle Born Peptides are laboratory reference materials for in-vitro research and analytical use by qualified professionals. They are not drugs, foods, dietary supplements, cosmetics or medical devices; they are not approved by the FDA or any other regulator for use in humans or animals; and they are not intended to diagnose, treat, cure, mitigate or prevent any disease, or to affect the structure or any function of the body of humans or animals. Nothing in this article is preparation, handling or dosing guidance. See our full research-use terms.